<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0">
  <channel>
    <title>PYC Financial Share News Feed - London South East</title>
    <link>http://www.lse.co.uk/</link>
    <description>PYC Financial Share News Feed - London South East</description>
    <language>en-us</language>
    <lastBuildDate>Fri, 24 May 2013 10:00:37 GMT</lastBuildDate>
    <copyright>2007 London South East</copyright>
    <docs>http://www.lse.co.uk/rss/</docs>
    <ttl>15</ttl>
    <item>
      <title>BRIEF-Physiomics comments on share price movement</title>
      <description>
    LONDON, Aug 7 (Reuters) - Physiomics PLC: 
    * Stmnt re share price movement 
    * There are no agreements in existence between sareum,physiomics which will 
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=99h4kmrjna1enl3</link>
      <pubDate>Tue, 07 Aug 2012 15:15:32 GMT</pubDate>
    </item>
    <item>
      <title>BRIEF-Physiomics notes positive results for VAL 201</title>
      <description>
    LONDON, May 29 (Reuters) - Physiomics PLC: 
    * Statement re share price movement 
    * Notes ValiRx Plc has today announced some positive results relating to their VAL 201 compound 
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=nl9ie5usvc48vj3</link>
      <pubDate>Tue, 29 May 2012 11:59:17 GMT</pubDate>
    </item>
    <item>
      <title>BRIEF-Physiomics says knows no reason for share price move</title>
      <description>
    LONDON, Feb 15 (Reuters) - Physiomics PLC: 
    * Stmnt re share price movement 
    * Not aware of any reason for the change in share price 
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=f3qvnt9ilcy67eo</link>
      <pubDate>Tue, 15 Feb 2011 17:13:44 GMT</pubDate>
    </item>
    <item>
      <title>STOCKS NEWS UK-Small cap pharmas buoyed by Sareum</title>
      <description>
    STOCKS NEWS                           Reuters 
       Europe                   Real-time Equity News 
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=fgl14ix80zp7c9c</link>
      <pubDate>Wed, 09 Feb 2011 16:02:38 GMT</pubDate>
    </item>
    <item>
      <title>BRIEF-Physiomics unaware of reason for share price rise</title>
      <description>
    LONDON, Feb 8 (Reuters) - Physiomics Plc: 
    * Stmnt re share price movement 
    * Directors can confirm that they are not aware of any reason for the change 
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=cqq3d81ln61q9y5</link>
      <pubDate>Tue, 08 Feb 2011 12:04:16 GMT</pubDate>
    </item>
    <item>
      <title>BRIEF-Physiomics knows no reason for share price move</title>
      <description>
    LONDON, Sept 22 (Reuters) - Physiomics Plc: 
    * Know of no reason for the recent movements in the company's share price 
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=u6upuzp4hhjrwrc</link>
      <pubDate>Wed, 22 Sep 2010 14:28:21 GMT</pubDate>
    </item>
    <item>
      <title>BRIEF-Physiomics knows no reason for share price move</title>
      <description>
    LONDON, Oct 16 (Reuters) - Physiomics Plc: 
    * Directors confirm they know of no reason for the recent movements in the company's share price 
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=7j9qxf43i2nt7md</link>
      <pubDate>Fri, 16 Oct 2009 15:47:40 GMT</pubDate>
    </item>
    <item>
      <title>BRIEF-Physiomics in talks with a number of companies</title>
      <description>
    LONDON, Oct 1 (Reuters) - Physiomics Plc: 
    * Is in discussion with a number of major players in the oncology sector 
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=tx0ik7eauc0nj9s</link>
      <pubDate>Thu, 01 Oct 2009 14:20:09 GMT</pubDate>
    </item>
    <item>
      <title>Physiomics sees FY revenue, grant income of at least 440,000 pounds</title>
      <description>
    LONDON (Thomson Financial) - Computational systems biology services company Physiomics Plc. said Monday it has secured new contracts, which along with grant income from the extension of the TEMPO contract, will result in full-year revenue and grant income of at least 440,000 pounds. 
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=rznad23aqem0tow</link>
      <pubDate>Mon, 28 Jul 2008 07:24:08 GMT</pubDate>
    </item>
    <item>
      <title>Physiomics says to perform 2 more oncology projects for Eli Lilly UPDATE</title>
      <description>
    (Adds background, live share price)
    LONDON (Thomson Financial) - Physiomics Plc. said it has agreed to perform two new cancer drug discovery research projects for Eli Lilly. 
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=9m7njqiis74n6z3</link>
      <pubDate>Mon, 14 Jul 2008 07:34:48 GMT</pubDate>
    </item>
    <item>
      <title>Physiomics says to perform 2 more oncology projects for Eli Lilly</title>
      <description>
    LONDON (Thomson Financial) - Physiomics Plc. said it has agreed to perform two new cancer drug discovery research projects for Eli Lilly. 
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=d0dlccaolu4lps1</link>
      <pubDate>Mon, 14 Jul 2008 07:17:48 GMT</pubDate>
    </item>
    <item>
      <title>UK smallcap opening - Physiomics soars after oncology projects boost</title>
      <description>
    LONDON (Thomson Financial) - Shares in Physiomics Plc. soared nearly 25 percent early on, as the group announced it is to perform 2 new oncology projects for Eli Lilly.
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=z44d95coezv5lz7</link>
      <pubDate>Mon, 14 Jul 2008 07:17:15 GMT</pubDate>
    </item>
    <item>
      <title>Physiomics says TEMPO project delivering in line with EC guidelines</title>
      <description>
    LONDON (Thomson Financial) - Systems biology company Physiomics Plc. said the three-year research programme 'TEMPO' is delivering in line with the European Commission guidelines and that it can continue as per the original grant proposal.
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=fua5oqhmpmto6l4</link>
      <pubDate>Tue, 20 May 2008 07:09:53 GMT</pubDate>
    </item>
    <item>
      <title>Physiomics says Billam lifts voting rights to 9.08 percent</title>
      <description>
    LONDON (Thomson Financial) - Systems biology company Physiomics Plc. said it has been notified that Billam AG bought 5.50 million Physiomics shares at an average price of 0.21 pence per share on April 21.
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=qqd87o6330foclm</link>
      <pubDate>Tue, 22 Apr 2008 09:00:28 GMT</pubDate>
    </item>
    <item>
      <title>Physiomics says H1 pretax loss widens but sees additional contracts ahead</title>
      <description>
    LONDON (Thomson Financial) - Physiomics Plc. reported a wider first-half pretax loss but said it is looking forward to securing additional contracts and repeat business from existing partners.
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=g28x8gv4bldjx7c</link>
      <pubDate>Mon, 31 Mar 2008 09:19:53 GMT</pubDate>
    </item>
    <item>
      <title>Physiomics says secures 50,000 stg funding from Billam via 7 pct loan notes</title>
      <description>
    LONDON (Thomson Financial) - Physiomics PLC said it has secured funding of 50,000 stg from Billam PLC, a substantial shareholder, in the form of 7 pct loan notes that expire on Dec 31, 2009, but are repayable on demand. 
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=r613qfdkujtkzj4</link>
      <pubDate>Fri, 15 Feb 2008 12:01:54 GMT</pubDate>
    </item>
    <item>
      <title>Physiomics says chairman John Pool, FD Edward Oliver resign</title>
      <description>
    LONDON (Thomson Financial) - Systems biology company Physiomics PLC said its chairman John Pool, finance director Edward Oliver and non-executive director Duncan Lipscombe have resigned with immediate effect.
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=v3de6s4wd8zumkb</link>
      <pubDate>Thu, 20 Dec 2007 11:49:47 GMT</pubDate>
    </item>
    <item>
      <title>Physiomics to access top life-sciences computer after Swansea University MOU</title>
      <description>
    LONDON (Thomson Financial) - Systems biology company Physiomics says it will help boost cancer research after signing a deal to use one of the world's most powerful computers.
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=05vjv9nxc5n3kcv</link>
      <pubDate>Mon, 17 Dec 2007 07:56:35 GMT</pubDate>
    </item>
    <item>
      <title>ValiRx develops cancer cell death model with Physiomics</title>
      <description>
    LONDON (Thomson Financial) - Cancer therapeutics specialist ValiRx PLC said its GeneICE technology has been successfully coupled with Physiomics PLC's In Silico simulation technology to generate a cancer cell death model.
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=np38yqluqo97um8</link>
      <pubDate>Wed, 12 Dec 2007 09:16:37 GMT</pubDate>
    </item>
    <item>
      <title>Physiomics FY pretax loss narrows helped by surge in sales</title>
      <description>
    LONDON (Thomson Financial) - Physiomics PLC narrowed its full year pretax loss helped by a surge in sales.
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=m60h8orafhgkw8d</link>
      <pubDate>Tue, 27 Nov 2007 11:23:31 GMT</pubDate>
    </item>
    <item>
      <title>Physiomics says Billam lifts stake in co to about 7.08 pct</title>
      <description>
    LONDON (Thomson Financial) - Healthcare group Physiomics PLC said Billam AG, which invests in growing companies, bought a further 3.49 mln shares at an average of 0.6 pence a share, lifting its stake in the company to about 26.56 mln shares or 7.08 pct.
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=izg0v51ds8g3rne</link>
      <pubDate>Mon, 24 Sep 2007 15:33:01 GMT</pubDate>
    </item>
    <item>
      <title>UK smallcap opening - Celtic Resources higher on bid approach</title>
      <description>
    LONDON (Thomson Financial) - Punters came for Celtic Resources, 22 pence higher at 225, after the operator of three mines in Kazakhastan received a preliminary approach which may or may not lead to an offer.
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=usu2e0ypv0g73zx</link>
      <pubDate>Tue, 18 Sep 2007 07:59:48 GMT</pubDate>
    </item>
    <item>
      <title>Physiomics says Billam lifts stake in company to 6.15 pct</title>
      <description>
    LONDON (Thomson Financial) - Healthcare group Physiomics PLC said Billam AG, which invests in growing companies, bought a further 3.97 mln shares at an average price of 0.6 pence a share, lifting its stake to about 23.075 mln shares or about 6.15 pct.
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=uebii45ox8xhvhq</link>
      <pubDate>Mon, 17 Sep 2007 17:51:50 GMT</pubDate>
    </item>
    <item>
      <title>Physiomics says Billam lifts stake in co to 5.09 pct; buys 4 mln shrs at 0.6p</title>
      <description>
    LONDON (Thomson Financial) - Healthcare group Physiomics PLC said Billam AG, which invests in growing companies, hiked its stake to 5.09 pct through the purchase of 4.0 mln shares at an average price of 0.6 pence each.
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=ew5ae67shqic2tz</link>
      <pubDate>Mon, 17 Sep 2007 11:28:21 GMT</pubDate>
    </item>
    <item>
      <title>Physiomics agrees cancer collaboration with Eli Lilly</title>
      <description>
    LONDON (Thomson Financial) - Physiomics PLC said it has signed a deal to collaborate with Eli Lilly on Lilly's cancer drug discovery research.
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=ea931pwbc9gdmyb</link>
      <pubDate>Mon, 17 Sep 2007 08:33:18 GMT</pubDate>
    </item>
    <item>
      <title>Physiomics says Billam hikes stake in co to 4.03 pct</title>
      <description>
    LONDON (Thomson Financial) - Physiomics PLC said Billam AG hiked its stake in the company to 4.03 pct through the purchase of 3.85 mln shares at an average price of 0.525 pence each.
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=jkf09773ii3uoqb</link>
      <pubDate>Mon, 13 Aug 2007 14:09:33 GMT</pubDate>
    </item>
    <item>
      <title>UK small caps stay higher at midday; Physiomics makes further gains</title>
      <description>
    LONDON (Thomson Financial) - UK smaller companies stayed higher at midday, continuing to reflect the mood of the wider market, with Physiomics gaining further on stakebuilding news. 
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=gm0gjmuczd3l7v6</link>
      <pubDate>Wed, 08 Aug 2007 11:26:31 GMT</pubDate>
    </item>
    <item>
      <title>Physiomics says Billam buys shares, now holds around 3 pct of voting rights</title>
      <description>
    LONDON (Thomson Financial) - Physiomics PLC said Billam AG, which invests in growing companies, has bought 3.25 mln shares at 0.22 pence each.
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=af62bmhqg7bbtmi</link>
      <pubDate>Tue, 07 Aug 2007 16:05:23 GMT</pubDate>
    </item>
    <item>
      <title>Physiomics names Christophe Chassagnole COO effective today</title>
      <description>
    LONDON (Thomson Financial) - Physiomics PLC said it has named Christophe Chassagnole as chief operating officer effective today.
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=khzjts9bzadmf4n</link>
      <pubDate>Fri, 18 May 2007 15:28:29 GMT</pubDate>
    </item>
    <item>
      <title>Physiomics narrows H1 pretax loss to 154,000 stg; sales dip</title>
      <description>
    LONDON (AFX) - Physiomics PLC narrowed its pretax loss for the first half to 154,000 stg, from 184,000 stg a year earlier, despite a dip in its sales and said it is looking forward to a period of growth and development.
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=n8bgr7w2r1re92x</link>
      <pubDate>Fri, 16 Mar 2007 11:47:59 GMT</pubDate>
    </item>
    <item>
      <title>ValiRx signs deal with Physiomics to reduce drug development time, cost</title>
      <description>
    LONDON (AFX) - Cancer therapeutics company ValiRx PLC said it has signed a new agreement with systems biology simulation company Physiomics PLC to use Physiomics' In Silico simulations of cellular processes to reduce the development time and costs of new cancer therapeutic compounds.
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=1mljc0exk5c5068</link>
      <pubDate>Thu, 15 Feb 2007 10:26:07 GMT</pubDate>
    </item>
    <item>
      <title>Physiomics withdraws share allotting resolutions from AGM</title>
      <description>
    LONDON (AFX) - Physiomics PLC said it withdrew two resolutions from its AGM giving it the authority to allot shares to raise up to 1.43 mln stg cash.
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=i7e56v91yfincz3</link>
      <pubDate>Tue, 02 Jan 2007 08:54:48 GMT</pubDate>
    </item>
    <item>
      <title>Physiomics FY pretax loss widens to 0.48 mln stg on falling sales of 0.11 mln</title>
      <description>
    LONDON (AFX) - Physiomics reported a FY pretax loss of 480,000 stg on sales of 113,000, compared to a loss of 432,000 on sales of 205,000 a year ago.
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=j1cwo6d67oru3dj</link>
      <pubDate>Thu, 07 Dec 2006 15:40:45 GMT</pubDate>
    </item>
    <item>
      <title>Physiomics replaces chairman, CFO; raises new funds; appoints new broker</title>
      <description>
    LONDON (AFX) - Healthcare group Physiomics PLC said its chairman, David Evans, is stepping down with immediate effect, with company director John Pool taking over until a permanent replacement is found.
</description>
      <link>http://www.lse.co.uk/ShareNews.asp?shareprice=PYC&amp;ArticleCode=5nwhri07agc6r1g</link>
      <pubDate>Fri, 01 Sep 2006 15:31:42 GMT</pubDate>
    </item>
  </channel>
</rss>